ASCO Annual Meeting brought many different updates to light in the realm of hematological malignancies, including multiple ...

Health and the Aspen Ideas Festival deeply inspired—by the setting, the community, and the shared pursuit of progress,” Brendan G. Carr has told Digital Journal. “This year, my colleagues will explore ...

In June 2025, Carmot Therapeutics Inc. announced a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of ...

If approved, daratumumab will be the first authorised treatment option for patients with smouldering multiple myeloma at high-risk of developing multiple myeloma, offering the potential for disease ...

People with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) have significant differences in their blood compared ...

Discover which therapies are expected to grab the HER2-low cancers market share @ HER2-low Cancers Market Report The HER2-low ...

Since 2006, the Molecular Foundry at the Department of Energy's Lawrence Berkeley National Laboratory has empowered thousands of researchers to ...

From the biology of aging to the future of artificial intelligence (AI)-driven medicine, Mount Sinai Health System will ...

Northwestern University’s International Institute for Nanotechnology (IIN) has announced the recipients of the 2025 ...